Non-alcoholic fatty liver diseases (NAFLD) is cause by accumulation of lipid droplets in liver. NAFLD is the starting point of liver disease and later develop into nonalcoholic steatohepatitis, cirrhosis and finally hepatocellular carcinoma. Since there is no specific therapeutics for NAFLD-related liver diseases, development of new drug for NAFLD/NASH is actively on-going. Recently, application of […]
Read More